OMICS International

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series Ltd: World’s leading Event Organizer

 

Recommended Conferences for BCG vaccine

BCG vaccine


Bacillus Calmette-Guerin (BCG) Vaccine
Bacillus Calmette-Guerin (BCG) Vaccine also called as Bacille de Calmette et Guérin or BCG, provides immunity or protection against tuberculosis (TB). The vaccine may be given to persons at high risk of developing tuberculosis (TB) disease. It is also used to treat bladder tumors or bladder cancer. Using BCG medicine, firstly the risks of taking the medicine must be weighed. This is a decision you and your doctor will make. For bacillus of calmette and guerin vaccine the following should be considered like Allergies, Pediatric, Geriatric, Pregnancy, Breast Feeding and Interactions with Food/Tobacco/Alcohol For a variable number of years after BCG vaccination, many people show a local skin reaction to the purified protein derived skin test (also called tuberculin skin test). Further testing for tuberculosis is often required in individuals given BCG vaccination in order to distinguish between a false-positive test result, in which an individual is not infected with tuberculosis, and a positive test result, in which an individual is infected with tuberculosis. Biological response modifiers are substances that have no direct antitumor effect but are able to trigger the immune system to indirectly affect tumors. BCG is thought to bring about an immune response in the bladder by triggering an inflammatory reaction in the bladder. This reaction brings disease-fighting white blood cells and cytokines to the bladder. The immune system cells then fight directly against the tumor cells. The cytokine response changes the environment in the bladder that may inhibit future tumor growth and progression. more
BCG symptoms of active TB are
•Weight loss
•Fever and night sweats
•Cough
•chest pains
•Weakness
Brand Names
TheraCys® BCG
TICE® BCG
BCG live
BCG vaccine

OMICS International Organizes 1000+ Global Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 100000 eminent personalities, reputed scientists as editorial board and organizing committee members. The conference series website will provide you list and details about the conference organize worldwide. 

Bacillus Calmette-Guerin (BCG) Vaccine
Bacillus Calmette-Guerin (BCG) Vaccine also called as Bacille de Calmette et Guérin or BCG, provides immunity or protection against tuberculosis (TB). The vaccine may be given to persons at high risk of developing tuberculosis (TB) disease. It is also used to treat bladder tumors or bladder cancer. Using BCG medicine, firstly the risks of taking the medicine must be weighed. This is a decision you and your doctor will make. For bacillus of calmette and guerin vaccine the following should be considered like Allergies, Pediatric, Geriatric, Pregnancy, Breast Feeding and Interactions with Food/Tobacco/Alcohol For a variable number of years after BCG vaccination, many people show a local skin reaction to the purified protein derived skin test (also called tuberculin skin test). Further testing for tuberculosis is often required in individuals given BCG vaccination in order to distinguish between a false-positive test result, in which an individual is not infected with tuberculosis, and a positive test result, in which an individual is infected with tuberculosis. Biological response modifiers are substances that have no direct antitumor effect but are able to trigger the immune system to indirectly affect tumors. BCG is thought to bring about an immune response in the bladder by triggering an inflammatory reaction in the bladder. 
 

Market analysis : Global revenue for BCG  vaccine was nearly $31.8 billion in 2011.This market is expected for BCG vaccine to increase from $55.6 billion in 2020. In the case of USA $13.3billion in 2011 ,but it will increase half of the percentage by the end of 2017. Geographically, south America, dominates the market followed by Europe. South America accounted for about 38% share in the BCG vaccine market in 2013 owing to the heavy investments by multinational companies in research and development of vaccine .

Upcoming conferences

Global Summit and Expo on Vaccines & Vaccination
Nov 30-Dec 02, 2015 San Francisco, USA

10th Euro Global Summit and Expo on Vaccines & Vaccination
June 16-18, 2016 Rome, Italy

11th Global Summit and Expo on Vaccines & Vaccination
Sept 12-14, 2016 Pheonix, USA

International Conference on Hepatitis Vaccines
Sept 26-28, 2016 Valencia, Spain

International Conferences on Tarvel Medicine and Vaccines
Aug 1-2, 2016 Seattle, USA

Children Vaccines World Congress
Oct 10-12, 2016 Kuala Lumpur, Malaysia

Annual Conference on Virulant HIV Vaccines
Oct 3-5, 2016 Miami, USA

12th Global Vaccines & Vaccination Summit and Expo
Oct 20-22, 2016 Dubai, UAE

13th Asia Pacific Global Summit and Expo on Vaccines & Vaccination
Nov 10-12, 2016 Melborne, Australia

5th International Conference and Exhibition on Immunology
Oct 24-26, 2016 Chicago, USA

International Conference on Cancer Immunology and Immunotherapy
July 28-30, 2016 Melborne, Australia

World Vaccine Congress  29-31  March 2016, USA

9th vaccine and ISV congress 18-20 Oct 2015 Seoul, South Korea

World Vaccine Congress Asia 2016 Singapore

Annual Conference on Vaccine Research April 18-20 2016 Baltimore USA

 

 

Relevant Associations and Societies

  • Canadian Society for the History of Medicine/Société canadienne
  • European Association of Urology
  • European Society for Medical Oncology – ESMO
  • American Nurses Association (ANA)
  • Infectious Diseases Society of America
  • Royal Society's Scientific Journal
  • American Association of Veterinary Laboratory Diagnosticians
  • Society of Pediatric Gastroenterology
  • TB Association of India (TAI)
  • The American Medical Association
  • Infectious Diseases Society of America
  • Edward Jenner Society
  • Center for Vaccine Awareness and Research, Texas
  • Global Polio Eradication Initiative, USA
  • Group on Immunization Education, USA
  • Immunization Action Coalition,USA
  • International Vaccine Access Center (IVAC),USA
  • National Adult and Influenza Immunization Summit (NAIIS)
  • Sabin Vaccine Institute,USA
  • Vaccine Ethics.org

Companies

  • Pfizer
  • Novartis
  • Roche
  • Merck & Co.,
  • Sanofi
  • GlaxoSmithKline
  • Johnson & Johnson
  • AstraZeneca
  • Lilly
  • Amgen
  • Takeda
  • Bristol-Myers Squibb
  • Boehringer Ingelheim
  • Novo NorDisk
  • Bayer
  • Astellas
  • Daiichi Sankyo
  • Otsuka
  • Gilead Sciences, Baxter
  • Merck KGaA, Eisai and
  • BiogenIdec

 

This page will be updated regularly.

This page was last updated on 11th Sep, 2015

Conferenceseries Destinations

Contact Us

Medical Conferences
Jessie Grace
jessie.grace@conferenceseries.com
1-702-508-5200 Ext:8031, 8041

Pharmaceutical Conferences
Badoni Victor
badoni.victor@conferenceseries.com
1-702-508-5200 Ext:8045, 8047

Immunology & Microbiology Conferences
Walker Smith
walker.smith@conferenceseries.com
1-702-508-5200 Ext:8031

Cancer Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Nursing and Healthcare Conferences
Jennifer Leny
jennifer.leny@conferenceseries.com
1-702-508-5200 Ext:8044

Diabetes Conferences
Stanley knight
stanley.knight@conferenceseries.com
1-702-508-5200 Ext:8040

Neuroscience Conferences
Sandeep Kumar
sandeep@conferenceseries.com
1-702-508-5200 Ext:8034

Dental Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Clinical and Biochemistry Conferences
Rohit Casper
rohit.casper@conferenceseries.com
1-702-508-5200 Ext:8033

Biotechnology Conferences
Ravi Vittal
ravi.vittal@conferenceseries.com
1-702-508-5200 Ext:8031, 8037

Material Science Conferences
Lucy Grey
lucygrey@conferenceseries.com
1-702-508-5200 Ext:8035

Genetics & Mol Biology Conferences
Stephen Bruce
stephen.bruce@conferenceseries.com
1-702-508-5200 Ext:8038

Engineering Conferences
Dolly A
dolly@conferenceseries.com
+1-702-508-5200 Ext:8051

Program Enquiries
Symposia/Workshops
Sponsorships
Media Partners | Advertising